University of Minnesota Gynecologic Oncology

Topics

• Ovarian cancer diagnosis and treatment 91
• Endometrial and Cervical Cancer Treatments 89
• Cervical Cancer and HPV Research 60
• Cancer survivorship and care 20
• Immune Cell Function and Interaction 15
• Uterine Myomas and Treatments 14
• Intraperitoneal and Appendiceal Malignancies 11
• BRCA gene mutations in cancer 9
• Gestational Trophoblastic Disease Studies 9
• PARP inhibition in cancer therapy 9
• Gynecological conditions and treatments 8
• Venous Thromboembolism Diagnosis and Management 8

Most cited

1. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 89 citations · Rahel Ghebre

2. Advances in the management of endometrial cancer.

   BMJ (Clinical research ed.) · 2025 · 76 citations · Britt Erickson

3. Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 99 citations · Melissa Geller

4. Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 96 citations · Melissa Geller

5. Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.

   Cell · 2023 · 75 citations · Boris Winterhoff

6. Online Medical Misinformation in Cancer: Distinguishing Fact From Fiction.

   JCO oncology practice · 2022 · 47 citations · Deanna Teoh

7. Telehealth in cancer care during COVID-19: disparities by age, race/ethnicity, and residential status.

   Journal of cancer survivorship : research and practice · 2022 · 50 citations · Rahel Ghebre

8. Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.

   Science translational medicine · 2022 · 71 citations · Melissa Geller